Top

European Radiology

Published in:

01-12-2003 | Letter to the Editor

Safety of the long-time monthly triple dose of a Gd-based contrast agent

Authors: Francesco Sardanelli, Gianluigi Mancardi, Massimo Filippi

Published in: European Radiology | Special Issue 6/2003

Excerpt

Sir, …

De Ridder F, De M, Stadnik T, Luypaert R, Osteaux M (2001) Severe adverse reactions with contrast agents for magnetic resonance: clinical experience in 30,000 MR examinations. JBR-BTR 84:150–152PubMed

Okada S, Katagiri K, Kumazaki T, Yokoyama H (2001) Safety of gadolinium contrast agent in hemodialysis patients. Acta Radiol 42:339–341PubMed

Kuhn MJ, Hammer GM, Swenson LC, Youssef HT, Gleason TJ (1994) MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients. Comput Med Imaging Graph 18:391–399PubMed

Van Dijk P, Sijens PE, Schmitz PI, Oudkerk M (1997) Gd-enhanced MR imaging of brain metastases: contrast as a function of dose and lesion size. Magn Reson Imaging 15:535–541PubMed

Filippi M, Yousry T, Campi A et al. (1996) Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 46:379–384PubMed

Filippi M, Rovaris M, Capra R et al. (1998) A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain 121:2011–2020CrossRefPubMed

Yousry TA, Fesl G, Walther E, Voltz R, Filippi M (1998) Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis. J Neurol Sci 158:221–225CrossRefPubMed

Thurnher SA, Capelastegui A, Del Olmo FH et al. (2001) Safety and effectiveness of single- versus triple-dose gadodiamide injection-enhanced MR angiography of the abdomen: a phase III double-blind multicenter study. Radiology 219:137–146PubMed

Albrecht T, Dawson P (2000) Gadolinium-DTPA as X-ray contrast medium in clinical studies. Br J Radiol 73:878–882PubMed

10.

Thomsen HS, Almèn T, Morcos SK (2002) Gadolinium-containing contrast media for radiographic examination: a position paper. Eur Radiol 12:2600–2605PubMed

11.

Svaland MG, Christensen T, Lundorf E (1994) Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study. Acta Radiol 35:396–399

12.

Mancardi GL, Saccardi R, Filippi M et al. (2001) Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 57:62–68PubMed

Title: Safety of the long-time monthly triple dose of a Gd-based contrast agent
Authors: Francesco Sardanelli
Gianluigi Mancardi
Massimo Filippi
Publication date: 01-12-2003
Publisher: Springer-Verlag
Published in: European Radiology / Issue Special Issue 6/2003
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-003-1830-y

2024 ASCO Annual Meeting

Springer Medicine

Safety of the long-time monthly triple dose of a Gd-based contrast agent

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 6/2003

Hepatocellular carcinoma in an ectopic Liver: CT findings

Reversed double PCL sign: unusual location of a meniscal fragment of the knee observed by MR imaging

Scimitar syndrome: morphological diagnosis and assessment of hemodynamic significance by magnetic resonance imaging

Neoplastic transformation and tumour-like lesions in Paget's disease of bone: a pictorial review

Sacral pseudotumor complicating iliac bone harvest: radiographic, CT and MRI appearances

Diverticular disease in CT colonography